FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-Mutated Non-Small Cell Lung Cancer

Aakash Desai: FDA Accelerated Approval of Datopotamab Deruxtecan for EGFRm NSCLC

U.S. FDA Publishes White Paper on Cybersecurity in Medical Product Manufacturing Technologies

Yan Leyfman: FDA Approves Yeztugo, a Game-Changing HIV Prevention Drug

Marty Makary: The Power Of AI and Big Data To Revolutionize Our Approach at the FDA

Aakash Desai Shared A Study Published In JTO on Datopotamab Deruxtecan In Patients With EGFR-mutated NSCLC

AI In Medicine: Top 3 Advances This Week Suggested by Samuel Hume

FDA’s Office of Clinical Pharmacology Released 2024 Annual Report

Vivek Subbiah: Why Every Rare Cancer Patient Deserves Molecular Profiling?

Amol Akhade shared an article: FDA Approves Perioperative Pembrolizumab Plus Radiation in HNSCC